Accuray Incorporated Net Assets
Accuray Incorporated net assets. Based on the latest financial reports, Accuray Incorporated (ARAY) has net assets worth $41.70 Million USD as of June 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($443.68 Million) and total liabilities ($401.98 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Also explore ARAY year-over-year net asset growth to track the company's year-over-year net asset growth rate.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $41.70 Million |
| % of Total Assets | 9.4% |
| Annual Growth Rate | N/A |
| 5-Year Change | -21.6% |
| 10-Year Change | -10.39% |
| Growth Volatility | 29.5 |
Net Assets of Accuray Incorporated (2002–2026)
Net assets of Accuray Incorporated from 2002 to 2026. This chart illustrates how Accuray Incorporated's net assets have evolved over time, based on quarterly financial data. See ARAY equity to assets ratio to measure how much of total assets are equity-financed.
Annual Net Assets for Accuray Incorporated (2002–2026)
The table below shows the annual net assets of Accuray Incorporated from 2002 to 2026. For live market cap and overall valuation, see how much is Accuray Incorporated worth.
| Year | Net Assets | Change |
|---|---|---|
| 2026-06-30 | $41.70 Million | -48.63% |
| 2025-06-30 | $81.17 Million | +80.04% |
| 2024-06-30 | $45.08 Million | -15.98% |
| 2023-06-30 | $53.66 Million | +0.88% |
| 2022-06-30 | $53.19 Million | -22.74% |
| 2021-06-30 | $68.84 Million | +8.18% |
| 2020-06-30 | $63.63 Million | +27.60% |
| 2019-06-30 | $49.87 Million | +2.55% |
| 2018-06-30 | $48.63 Million | +4.51% |
| 2017-06-30 | $46.53 Million | -22.00% |
| 2016-06-30 | $59.66 Million | -21.27% |
| 2015-06-30 | $75.78 Million | -23.10% |
| 2014-06-30 | $98.55 Million | -7.76% |
| 2013-06-30 | $106.83 Million | -47.60% |
| 2012-06-30 | $203.87 Million | -15.17% |
| 2011-06-30 | $240.33 Million | +41.31% |
| 2010-06-30 | $170.08 Million | +10.51% |
| 2009-06-30 | $153.90 Million | +17.70% |
| 2008-06-30 | $130.76 Million | +4.24% |
| 2007-06-30 | $125.44 Million | +255.15% |
| 2006-06-30 | $-80.86 Million | -43.94% |
| 2005-06-30 | $-56.17 Million | -69.97% |
| 2003-06-30 | $-33.05 Million | -39.84% |
| 2002-06-30 | $-23.63 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Accuray Incorporated's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 56846600000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Accuray Incorporated Net Assets Breakdown (June 2026)
Accuray Incorporated net assets breakdown by equity component as of June 2026.
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $119.00K | 0.29% |
| Other Comprehensive Income | $-3.51 Million | -8.42% |
| Other Components | $613.56 Million | 1471.40% |
| Total Equity | $41.70 Million | 100.00% |
Accuray Incorporated Competitors by Market Cap
The table below lists competitors of Accuray Incorporated ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
China Times Publishing Co
TWO:8923
|
$17.13 Million |
|
Xilam Animation
PA:XIL
|
$17.14 Million |
|
Passat Société Anonyme
PA:PSAT
|
$17.14 Million |
|
SMRT Holdings Bhd
KLSE:0117
|
$17.15 Million |
|
Mighty Kingdom Ltd
AU:MKL
|
$17.13 Million |
|
CT AUTOMOTIVE GROUP -005
F:X7X
|
$17.12 Million |
|
Photon Energy N.V.
WAR:PEN
|
$17.12 Million |
|
Cosmos Exploration Ltd
AU:C1X
|
$17.12 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Accuray Incorporated's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2025 to 2026, total equity changed from 81,169,000 to 41,699,000, a change of -39,470,000 (-48.6%).
- Net loss of 49,194,000 reduced equity.
- New share issuances of 665,000 increased equity.
- Other comprehensive income decreased equity by 1,676,000.
- Other factors increased equity by 10,735,000.
Equity Change Factors (2025 to 2026)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-49.19 Million | -117.97% |
| Share Issuances | $665.00K | +1.59% |
| Other Comprehensive Income | $-1.68 Million | -4.02% |
| Other Changes | $10.73 Million | +25.74% |
| Total Change | $- | -48.63% |
Book Value vs Market Value Analysis
This analysis compares Accuray Incorporated's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.42x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2002-06-30 | $-2.24 | $0.14 | x |
| 2003-06-30 | $-3.12 | $0.14 | x |
| 2005-06-30 | $-3.93 | $0.14 | x |
| 2006-06-30 | $-5.05 | $0.14 | x |
| 2007-06-30 | $4.08 | $0.14 | x |
| 2008-06-30 | $2.16 | $0.14 | x |
| 2009-06-30 | $2.62 | $0.14 | x |
| 2010-06-30 | $2.83 | $0.14 | x |
| 2011-06-30 | $3.82 | $0.14 | x |
| 2012-06-30 | $2.76 | $0.14 | x |
| 2013-06-30 | $1.46 | $0.14 | x |
| 2014-06-30 | $1.30 | $0.14 | x |
| 2015-06-30 | $0.97 | $0.14 | x |
| 2016-06-30 | $0.74 | $0.14 | x |
| 2017-06-30 | $0.56 | $0.14 | x |
| 2018-06-30 | $0.57 | $0.14 | x |
| 2019-06-30 | $0.57 | $0.14 | x |
| 2020-06-30 | $0.70 | $0.14 | x |
| 2021-06-30 | $0.75 | $0.14 | x |
| 2022-06-30 | $0.58 | $0.14 | x |
| 2023-06-30 | $0.57 | $0.14 | x |
| 2024-06-30 | $0.46 | $0.14 | x |
| 2025-06-30 | $0.79 | $0.14 | x |
| 2026-06-30 | $0.34 | $0.14 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Accuray Incorporated utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -117.97%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -12.24%
- • Asset Turnover: 0.91x
- • Equity Multiplier: 10.64x
- Recent ROE (-117.97%) is below the historical average (-25.24%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2002 | 0.00% | -29.95% | 1.62x | 0.00x | $-3.43 Million |
| 2003 | 0.00% | -584.50% | 0.08x | 0.00x | $-12.54 Million |
| 2005 | 0.00% | -112.57% | 0.26x | 0.00x | $-19.57 Million |
| 2006 | 0.00% | -63.70% | 0.38x | 0.00x | $-25.61 Million |
| 2007 | -4.48% | -4.00% | 0.42x | 2.65x | $-18.16 Million |
| 2008 | 4.12% | 2.56% | 0.71x | 2.26x | $-7.69 Million |
| 2009 | 0.40% | 0.26% | 0.85x | 1.78x | $-14.78 Million |
| 2010 | 1.67% | 1.28% | 0.84x | 1.55x | $-14.17 Million |
| 2011 | -11.61% | -12.00% | 0.49x | 1.98x | $-49.66 Million |
| 2012 | -36.83% | -17.60% | 0.86x | 2.42x | $-91.60 Million |
| 2013 | -96.62% | -32.67% | 0.66x | 4.45x | $-113.90 Million |
| 2014 | -35.97% | -9.60% | 0.75x | 5.02x | $-45.30 Million |
| 2015 | -53.06% | -10.59% | 0.81x | 6.20x | $-47.79 Million |
| 2016 | -42.75% | -6.40% | 0.85x | 7.86x | $-31.47 Million |
| 2017 | -63.57% | -7.71% | 0.94x | 8.73x | $-34.23 Million |
| 2018 | -49.14% | -5.90% | 1.07x | 7.79x | $-28.76 Million |
| 2019 | -32.94% | -3.92% | 0.96x | 8.79x | $-21.42 Million |
| 2020 | 6.01% | 1.00% | 0.78x | 7.71x | $-2.54 Million |
| 2021 | -9.17% | -1.59% | 0.83x | 6.97x | $-13.20 Million |
| 2022 | -10.05% | -1.24% | 0.91x | 8.89x | $-10.67 Million |
| 2023 | -17.29% | -2.07% | 0.93x | 8.93x | $-14.65 Million |
| 2024 | -34.48% | -3.48% | 0.95x | 10.39x | $-20.05 Million |
| 2025 | -1.96% | -0.35% | 0.98x | 5.79x | $-9.71 Million |
| 2026 | -117.97% | -12.24% | 0.91x | 10.64x | $-53.36 Million |
Industry Comparison
This section compares Accuray Incorporated's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $296,528,539
- Average return on equity (ROE) among peers: -35.30%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Accuray Incorporated (ARAY) | $41.70 Million | 0.00% | 9.64x | $17.13 Million |
| Abbott Laboratories (ABT) | $2.83 Billion | 34.08% | 0.96x | $190.23 Billion |
| Adagio Medical Holdings, Inc Common Stock (ADGM) | $-95.88 Million | 0.00% | 0.00x | $2.34 Million |
| Aethlon Medical Inc (AEMD) | $-3.66 Million | 0.00% | 0.00x | $1.11 Million |
| Acutus Medical Inc (AFIB) | $-11.59 Million | 0.00% | 0.00x | $903.35K |
| Adapthealth Corp (AHCO) | $15.14 Million | -140.98% | 14.05x | $850.46 Million |
| 20/20 Biolabs, Inc. Common Stock (AIDX) | $9.37 Million | 23.33% | 0.30x | $2.43 Million |
| Allurion Technologies, Inc. (ALUR) | $-77.98 Million | 0.00% | 0.00x | $21.01K |
| Autonomix Medical, Inc. Common Stock (AMIX) | $5.89 Million | -283.55% | 0.29x | $1.61 Million |
| Artivion Inc (AORT) | $276.20 Million | -4.84% | 1.86x | $1.03 Billion |
| Apyx Medical Inc (APYX) | $14.18 Million | 18.92% | 0.18x | $109.52 Million |
About Accuray Incorporated
Accuray Incorporated engages in the design, development, manufacture, and sale of radiosurgery and radiation therapy systems for the treatment of tumors in the United States, Canada, Latin America, Asia, Australia, New Zealand, Europe, the Middle East, India, Africa, Japan, and China. The company offers the CyberKnife platform, a robotic stereotactic radiosurgery and stereotactic body radiation t… Read more